Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

AstraZeneca and Eli Lilly have formed an agreement to jointly develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. ​Under the...

Baxter International Inc. and Halozyme Therapeutics, Inc., have received approval from the US Food and Drug Administration (FDA) for Baxter's subcutaneous treatment, Hyqvia (immune globulin infusion 10% (human) with recombinant human...

Lupin Limited, a Mumbai-headquartered pharmaceutical company, and the specialty pharmaceutical company, Salix Pharmaceuticals, Inc., have formed a definitive distribution agreement under which Salix has granted Lupin the exclusive right to market,...

The biopharmaceutical companies, Seattle Genetics and Genmab A/S, have formed an additional antibody-drug conjugate (ADC) collaboration with potential value of more than $200 million. Under the new agreement, Genmab will pay an...

Novo Nordisk reports that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the United States Food and Drug Administration (FDA) has recommended for approval the company's new drug application (NDA) for Saxenda, the intended...

GlaxoSmithKline (GSK) has formed a Â£5-million ($8.1-million) collaboration with the UK and South African Medical Research Councils(MRCs) to support research into non-communicable diseases (NCDs) in Africa as part of GSK's Africa...

The US Food and Drug Administration has approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) from Takeda Pharmaceuticals and the biopharmaceutical company, Orexigen Therapeutics, as treatment...

Baxter International Inc. has announced that Baxalta Incorporated will be the name of the new, publicly traded biopharmaceutical company that is expected to launch in mid-2015. In March 2014, Baxter announced that it planned to create two...

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, is expanding through the addition of manufacturing lines and solar array assembly at the company's Optics Center in Rochester, New York. The company...